CureVac N.V.

NASDAQ: CVAC · Real-Time Price · USD
5.49
-0.02 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
5.55
1.18%
After-hours: Aug 15, 2025, 07:35 PM EDT

CureVac Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
523.7M 535.18M 542.7M 65.28M 58.42M 53.18M 42.88M 37.61M 50.18M 67.42M 96.96M 115.08M 117.33M 102.99M 67.77M 43.59M 55.74M
Cost of Revenue
65.02M 105.83M 164.11M 166.46M 151.59M 130.53M 150.77M 150.57M 167.4M 183.99M 174.01M 264.95M 259.67M 238.19M 175.3M 62.25M 25.26M
Gross Profit
458.69M 429.35M 378.59M -101.18M -93.16M -77.35M -107.89M -112.96M -117.22M -116.57M -77.05M -149.87M -142.33M -135.21M -107.54M -18.67M 30.48M
Operating Income
196.27M 177.68M 131.04M -291.37M -289.56M -276.59M -307.7M -306.05M -294.54M -249.46M -133.46M -224.17M -311.7M -412.26M -453.35M -347.02M -202.39M
Interest Income
11.99M 12.36M 8.64M 15.75M 19.41M 19.53M 19.53M 15.36M 12.49M 10.62M 11.89M 8.15M 5.17M 10.1M 8.83M 11.17M 11.02M
Pretax Income
209.11M 190.88M 145.17M -274.07M -270.22M -257.75M -302.23M -301.2M -291.38M -249.16M -124.96M -220.83M -315.45M -412.5M -465.24M -358.42M -218.23M
Net Income
180.66M 162.19M 110.52M -276.21M -271.08M -257.94M -302.3M -301.19M -291.36M -249.03M -122.18M -218.64M -313.11M -411.72M -467.08M -359.89M -218.13M
Selling & General & Admin
63.69M 63.04M 66.16M 67.91M 73.53M 76.43M 78.42M 84.51M 88.52M 89.41M 80.35M 80.93M 89.64M 88.94M 86.14M 72.71M 55.59M
Research & Development
162.8M 153.03M 138.27M 115.54M 115.31M 111.74M 109.98M 95.25M 76.02M 62.55M 566.11M 602.06M 721.71M 815.91M 322.2M 308.31M 207.89M
Other Expenses
38.44M 38.44M 42.17M 2.79M n/a 3.2M 5.6M 10.52M 14.5M -17.68M -589.14M -607.77M -641.99M -627.79M -62.45M -52.58M -29.72M
Operating Expenses
262.41M 252.59M 248.47M 191.6M 197.96M 200.2M 201.25M 194.05M 179.03M 134.28M 57.32M 75.22M 169.36M 277.06M 352.94M 335.47M 240.8M
Interest Expense
-7K n/a 636K 4.58M 6.21M 6.82M 14.93M 11.38M 10.19M 11.19M 3.4M 4.81M 8.93M 10.34M 20.63M 22.49M 26.77M
Selling & Marketing Expenses
2.46M 1.6M 436K 407K 420K 423K 438K 386K 254K 417K 831K 941K 1.54M 1.74M 1.16M 753K 880K
Cost & Expenses
327.43M 358.42M 412.58M 358.05M 349.55M 330.73M 352.02M 344.62M 346.43M 318.27M 231.33M 340.18M 429.03M 515.25M 521.12M 390.6M 258.13M
Income Tax Expense
28.46M 28.7M 34.66M 2.13M 858.77K 193.77K 67K -17K -29K -126K -2.78M -2.19M -2.34M -782K 2.73M 2.36M 783K
Shares Outstanding (Basic)
225.15M 224.34M 224.31M 224.31M 224.29M 223.99M 223.91M 223.88M 211.44M 195M 184.09M 184.09M 184.09M 180.46M 180.46M 180.46M 184.09M
Shares Outstanding (Diluted)
225.15M 224.79M 224.31M 224.31M 224.29M 223.99M 223.91M 223.88M 211.44M 195M 184.09M 184.09M 184.09M 180.46M 180.46M 180.46M 187.03M
EPS (Basic)
0.81 0.73 0.50 -1.23 -1.21 -1.17 -1.45 -1.49 -1.5 -1.31 -0.66 -1.2 -1.73 -2.27 -2.58 -1.98 -1.2
EPS (Diluted)
0.81 0.73 0.50 -1.23 -1.21 -1.17 -1.45 -1.49 -1.5 -1.31 -0.66 -1.2 -1.73 -2.26 -2.57 -1.97 -1.19
EBITDA
227.63M 202.15M 155.72M -258.18M -252.19M -236.32M -280.91M -282.64M -272.07M -219.88M -115.17M -211.61M -306.29M -407.78M -444.19M -340.23M -199.16M
EBIT
209.11M 190.88M 139.26M -276.04M -270.56M -257.48M -294.78M -297.3M -288.67M -245.45M -121.56M -216.02M -306.53M -402.16M -447.6M -338.92M -194.45M
Depreciation & Amortization
18.52M 19.07M 23.85M 25.62M 26.28M 27.09M 21.38M 21.82M 23.57M 26.89M 46.52M 44.52M 40.38M 34.42M 14.85M 10.96M 9.39M